Utama › Dermatitis Atopik (Eksim) › California › Los Angeles
Kajian klinikal Dermatitis Atopik (Eksim) di Los Angeles, CA
11 kajian untuk Dermatitis Atopik (Eksim) sedang mencari peserta di lokasi dalam dan sekitar Los Angeles (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment
Mengambil pesertaKajian pemerhatian
- Dermatology Research Associates - Los Angeles- Site Number : 8400020, Los Angeles
Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis
Mengambil pesertaFasa 2
- Novartis Investigative Site, Los Angeles
A Study to Learn About Study Medicine Called PF-08049820 in People With Eczema
Mengambil pesertaFasa 2
- Metropolis Dermatology - DTLA, Los Angeles
A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis
Mengambil pesertaFasa 2
- Investigational Site, Los Angeles
A Long Term Extension Study to Evaluate the Safety and Efficacy of Afimkibart (RO7790121) in Participants With Atopic Dermatitis
Mengambil pesertaFasa 2
- UCLA Division of Dermatology, Los Angeles
- Dermatology Research Associate, Los Angeles
A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
Mengambil pesertaFasa 2
- Metropolis Dermatology, Los Angeles
- Dermatology Research Associates, Los Angeles
- University of California Los Angeles, Los Angeles
A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
Mengambil pesertaFasa 2
- Inmagene Site 23, Los Angeles
A Phase 2b Dose-Ranging Study to Evaluate the Efficacy and Safety of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis
Mengambil pesertaFasa 2
- Enveda Investigative Site, Los Angeles
Evaluate Efficacy and Safety of Repeat Subcutaneous Doses of FB825 in Adults With Moderate-to-Severe Atopic Dermatitis
Mengambil pesertaFasa 2
- California Allergy and Asthma Medical Group, Los Angeles
A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis
Mengambil pesertaFasa 2
- California Allergy and Asthma Medical Group, Los Angeles
Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults
Mengambil pesertaKajian pemerhatian
- Galderma Investigational Site 7099, Los Angeles
Kajian Dermatitis Atopik (Eksim) di bandar lain
- New York City, NY13 kajian
- Washington, DC11 kajian
- San Antonio, TX10 kajian
- San Diego, CA10 kajian
- Birmingham, AL9 kajian
- Miami, FL9 kajian
- Dallas, TX8 kajian
- Huntington Beach, CA8 kajian
- Sacramento, CA8 kajian
- Troy, MI8 kajian
- Indianapolis, IN7 kajian
- Pittsburgh, PA7 kajian
Kajian lain di Los Angeles
- Kanser Paru-paru Bukan Sel Kecil87 kajian
- Kanser (semua jenis)74 kajian
- Kanser Payudara73 kajian
- Kanser Prostat61 kajian
- Kanser Kolorektal59 kajian
- Kanser Metastatik57 kajian
- Kanser Ovari50 kajian
- Kanser Paru-paru45 kajian
- Karsinoma Sel Skuamosa Kepala dan Leher42 kajian
- Kanser Pankreas35 kajian
- Kanser Endometrium34 kajian
- Melanoma34 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.